Chargement en cours...

Current and projected annual direct costs of screening asymptomatic men for prostate cancer using prostate-specific antigen

BACKGROUND: Concern over the cost of screening for asymptomatic prostate cancer by means of prostate-specific antigen (PSA) testing has played an important role in PSA screening policy. However, little is known about the true costs of current PSA screening in Canada and how costs may change in the f...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Krahn, M D, Coombs, A, Levy, I G
Format: Artigo
Langue:Inglês
Publié: 1999
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1229945/
https://ncbi.nlm.nih.gov/pubmed/9934343
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!